Sweden Biotechnology & Medical Research

Hamlet BioPharma AB (HAMLET-B)

Track

Track

Hamlet BioPharma AB experienced notable insider activity during May 2026. Board member Henrik Sundin executed multiple sell orders totaling 80,000 shares. Previously, Chairman Marianne Catharina Svanborg purchased 25,000 shares in March. These transactions represent the most recent shifts in equity ownership reported by company leadership.
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Henrik Sundin Member of the Board of Directors Director
Through HS Compliance Partner AB, a closely affiliated person
Transaction date
Sale
Price
428.37
Quantity 7,474
Value SEK2,777,029
Henrik Sundin Member of the Board of Directors Director
Through HS Compliance Partner AB, a closely affiliated person
Transaction date
Sale
Price
429.60
Quantity 2,237
Value SEK1,403,886
Henrik Sundin Member of the Board of Directors Director
Through HS Compliance Partner AB, a closely affiliated person
Transaction date
Sale
Price
185.56
Quantity 8,125
Value SEK326,137
Henrik Sundin Member of the Board of Directors Director
Through HS Compliance Partner AB, a closely affiliated person
Transaction date
Sale
Price
7.65
Quantity 20,000
Value SEK153,000
Henrik Sundin Member of the Board of Directors Director
Through HS Compliance Partner AB, a closely affiliated person
Transaction date
Sale
Price
7.58
Quantity 10,000
Value SEK75,800
Henrik Sundin Member of the Board of Directors Director
Through HS Compliance Partner AB, a closely affiliated person
Transaction date
Sale
Price
7.70
Quantity 20,000
Value SEK154,000
Marianne Catharina Svanborg Chairman of the Board of Directors Director
Transaction date
Purchase
Price
6.98
Quantity 25,000
Value SEK174,500
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-25 2026-05-25 S Sale
Henrik Sundin

Member of the Board of Directors

Through HS Compliance Partner AB, a closely affiliated person Director
7,474
428.37
SEK2,777,029 		7,474 428.37 SEK2,777,029
2026-05-25 2026-05-22 S Sale
Henrik Sundin

Member of the Board of Directors

Through HS Compliance Partner AB, a closely affiliated person Director
2,237
429.60
SEK1,403,886 		2,237 429.60 SEK1,403,886
2026-05-25 2026-05-22 S Sale
Henrik Sundin

Member of the Board of Directors

Through HS Compliance Partner AB, a closely affiliated person Director
8,125
185.56
SEK326,137 		8,125 185.56 SEK326,137
2026-05-25 2026-05-22 S Sale
Henrik Sundin

Member of the Board of Directors

Through HS Compliance Partner AB, a closely affiliated person Director
20,000
7.65
SEK153,000 		20,000 7.65 SEK153,000
2026-05-25 2026-05-22 S Sale
Henrik Sundin

Member of the Board of Directors

Through HS Compliance Partner AB, a closely affiliated person Director
10,000
7.58
SEK75,800 		10,000 7.58 SEK75,800
2026-05-25 2026-05-22 S Sale
Henrik Sundin

Member of the Board of Directors

Through HS Compliance Partner AB, a closely affiliated person Director
20,000
7.70
SEK154,000 		20,000 7.70 SEK154,000
2026-03-29 2026-03-26 B Purchase
Marianne Catharina Svanborg

Chairman of the Board of Directors

Director
25,000
6.98
SEK174,500 		25,000 6.98 SEK174,500
Explore more

More insider trading research around Hamlet BioPharma AB

More insider trades in Sweden
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe